Western blot and transwell assays identified that ZNF671 inhibited epithelial-mesenchymal transition, migration, and invasion of central nervous system cancers, lung cancer, melanoma, and breast carcinoma in vitro [30]. This evidence concerns the gene ZNF671 and melanoma.